全球冷痛治療市場：COVID-19 的增長、趨勢、影響、預測（2021-2026 年）
Cold Pain Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
|出版商||Mordor Intelligence Pvt Ltd||商品編碼||1005793|
|出版日期||內容資訊||英文 111 Pages
|全球冷痛治療市場：COVID-19 的增長、趨勢、影響、預測（2021-2026 年） Cold Pain Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)|
|出版日期: 2021年04月21日||內容資訊: 英文 111 Pages||
在 2021-2026 年的預測期內，冷痛治療的市場規模預計將以 4.5% 的複合年增長率增長。
此外，道路交通事故和相關傷害的增加也促進了市場的增長。根據世界衛生組織 (WHO) 的數據，全世界每年有 20 至 5000 萬人遭受非致命傷害。然而，在預測期內，對冷痛治療缺乏認識預計將阻礙市場增長。有幾個因素促進了發達和新興市場醫院中患者的治療，並且主要與主要由醫療機構管理的各個行業中的意外病例有關。因此，生物製藥和醫療器械公司的主要重點是加強推動市場增長的醫療機構的分銷網絡和供應。
The cold pain therapy market is projected to grow ar CAGR of 4.5% over the forecast period. Owing to increasing cases of injuries related to sports and the adoption of quick pain relieving technologies market is expected to grow at significant rates.
Due to the impact of the COVID 19 pandemic, the cold pain therapy market is projected to have a short-term decline owing to the lockdown situations and scarcity of the stock due to the supply chain disruptions coupled with the decreased trauma and pain-related hospital admissions. In addition, the growing prevalence of bone disorders such as arthritis and an aging population are anticipated to boost the market growth.
Furthermore, an increasing number of road accidents and related injuries are also responsible for market growth. According to the World Health Organization (WHO), each year 20 to 50 million people suffer from non-fatal injuries around the world. However, the lack of awareness regarding cold therapy is expected to hinder the market growth over the forecast period. There are several factors that drives the patient treatment in hospitals across developed and emerging markets and [primarily related to accidental cases across different industries which is primarily controlled in the healthcare facilities. Thus, the major focus of the biopharmaceutical and medical device companies is enhance their distribution network and supplies across healthcare facilities which boost the growth of the market.
OTC Products Holds Majority of the Share in Product Segment Followed by Prescription Based
OTC product segment holds the majority of market share owing to easy availability and advent of e-commerce around the world. Moreover, the high prevalence of musculoskeletal disorders and advancements in product technologies in providing rapid pain relief is fuelling the segment growth. Furthermore, the availability of a wide range of products such as gels, patches, cold packs, roll-ons, and sprays is expected to boost the OTC product segment growth rate over the forecast period. For instance, in march 2019, Performance Health has expanded its product portfolio with the launch of the Biofreeze pain relief patch.
Moreover, the sports medicine segment is expected to have a significant growth rate over the forecast period owing to the increasing incidence of sports injuries and the advent of instant pain-relieving products. An increasing incidence of post-traumatic pain and growing affordability of medicine anticipated bolstering the market growth furthermore. The aging population around the world, having a high risk of musculoskeletal disorders and pain complementing the growth of the cold pain therapy market.
However, with the impact of COVID 19 pandemic, application segments such as sports medicine and post operative therapies are expected to witness slight decline in revenue due to the low activity in the segment. However, post pandemic situation expected to provide lucrative opportunity for growth over the forecast period.
North America Dominates the Cold Pain Therapy Market
North America holds a significant share owing to factors such as increased awareness and availability of advanced product technologies including non-motorized and motorized cold pain therapy devices. Furthermore, the ageing population and availability of a large pool of patients with back pain and other injuries are anticipated to drive the market growth over the forecast period. As per the Population Reference Bureau's fact sheet, the number of Americans above 65 is projected to nearly double from 52 million in 2018 to 95 million by 2060. The 65-and-older age group's share in the total population may rise from 16% to 23%. Also, according to the Morbidity and Mortality Weekly Report, Centre for Disease Control and Prevention, 2018, chronic pain affects about 50 million adults in the United States. High-impact chronic pain is affected by around 20 million adult populations in the United States.
Amid COVID 19, chronic pain management is still quite a challenging process, especially with growing evidence that the virus infection is associated with myalgias, referred pain, and widespread hyperalgesia. Anaesthesia and pain medicine healthcare professionals responsible for performing spinal interventions and regional anesthetic blockades are at a higher risk of infection than any other medical specialties.
Europe followed by the Asia Pacific expected to grow at significant rates owing to growing awareness and improving healthcare infrastructure in middle and low-income countries. According to the World Health Organization (WHO), 93% of the world fatalities due to road accidents happen in low and middle-income countries even though these countries have approximately 60% of the world's vehicles. Hence, increase in the incidence of road accidents and the increasing popularity of OTC products in the Asia Pacific are fueling the market growth in the region.
The cold pain therapy market is moderately fragmented having more number of market players. There are well-established market players that are gaining momentum utilizing e-commerce and expanding into new regions. The key market players include Breg Inc., Cardinal Health, Inc., DJO Global Inc. and Ossur hf. among others. Also, the market is witnessing entry of new market players and product launches, likely to boost the overall market growth. For instance, in March 2020, Tammy Lee has founded Xena Cool, a manufacturing company offering wearable cool therapy knee, shoulder and back/hip devices designed for active use and mobility.